NO931246L - Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv) - Google Patents

Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)

Info

Publication number
NO931246L
NO931246L NO93931246A NO931246A NO931246L NO 931246 L NO931246 L NO 931246L NO 93931246 A NO93931246 A NO 93931246A NO 931246 A NO931246 A NO 931246A NO 931246 L NO931246 L NO 931246L
Authority
NO
Norway
Prior art keywords
hbv
virus
disease caused
compositions
hepatites
Prior art date
Application number
NO93931246A
Other languages
English (en)
Other versions
NO931246D0 (no
Inventor
Dennis W Adair
Kenneth A Smiles
Dannie King
Original Assignee
Oclassen Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oclassen Pharma Inc filed Critical Oclassen Pharma Inc
Publication of NO931246D0 publication Critical patent/NO931246D0/no
Publication of NO931246L publication Critical patent/NO931246L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Farmasosytiske sammensetninger nyttige for behandling av individer som lider av en infeksjon eller sykdom forårsaket av hepatit B virus (HBV) er beskrevet. Det er spesielt blitt oppdaget at administrering av lave dosemengder av l-(2'-deoksy-2'-fluoro-B-D-arabino- furanosyl)-5-iodouracil (FIAU) til mennsker som er kronisk infisert med HBV effektivt kan redusere drastisk sirkulerende markører assosiert med HBV. Fremgangsmåter for fremstilling av farmasøytiske antivirale sammensetninger er også beskrevet.
NO93931246A 1992-04-06 1993-03-31 Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv) NO931246L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US86389092A 1992-04-06 1992-04-06
US95292792A 1992-09-25 1992-09-25
US07/959,004 US5432165A (en) 1992-04-06 1992-10-09 Methods for the treatment of infection caused by Hepatitis B virus (HBV)

Publications (2)

Publication Number Publication Date
NO931246D0 NO931246D0 (no) 1993-03-31
NO931246L true NO931246L (no) 1993-10-07

Family

ID=27420427

Family Applications (1)

Application Number Title Priority Date Filing Date
NO93931246A NO931246L (no) 1992-04-06 1993-03-31 Sammensetninger for behandling av infeksjon og sykdom foraarsaket av hepatites b virus (hbv)

Country Status (26)

Country Link
US (1) US5432165A (no)
EP (1) EP0565412A1 (no)
JP (1) JPH069403A (no)
CN (1) CN1081879A (no)
AP (1) AP372A (no)
AU (1) AU662804B2 (no)
BE (1) BE1009181A5 (no)
BR (1) BR9306207A (no)
CA (1) CA2092356A1 (no)
EE (1) EE9400068A (no)
ES (1) ES2105923B1 (no)
FR (1) FR2689398B1 (no)
GR (1) GR930100111A (no)
IL (1) IL105169A0 (no)
IT (1) IT1264332B1 (no)
LV (1) LV10191B (no)
MD (1) MD940152A (no)
MX (1) MX9301922A (no)
NO (1) NO931246L (no)
NZ (1) NZ247188A (no)
OA (1) OA10102A (no)
PH (1) PH31116A (no)
PT (1) PT101238A (no)
SI (1) SI9300144A (no)
WO (1) WO1993019762A1 (no)
YU (1) YU23993A (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5827727A (en) * 1990-02-01 1998-10-27 Emory University Method of resolution of 1,3-oxathiolane nucleoside enantiomers
US5444063A (en) * 1990-12-05 1995-08-22 Emory University Enantiomerically pure β-D-dioxolane nucleosides with selective anti-Hepatitis B virus activity
US6200952B1 (en) 1993-06-02 2001-03-13 Sciclone Pharmaceuticals, Inc. Combination therapy method for treating chronic hepatitis B
US5587362A (en) * 1994-01-28 1996-12-24 Univ. Of Ga Research Foundation L-nucleosides
WO1996010649A1 (en) * 1994-09-30 1996-04-11 Southwest Foundation For Biomedical Research Isolated human hepatitis b virus polymerase and uses thereof
US5703058A (en) * 1995-01-27 1997-12-30 Emory University Compositions containing 5-fluoro-2',3'-didehydro-2',3'-dideoxycytidine or a mono-, di-, or triphosphate thereof and a second antiviral agent
US6391859B1 (en) 1995-01-27 2002-05-21 Emory University [5-Carboxamido or 5-fluoro]-[2′,3′-unsaturated or 3′-modified]-pyrimidine nucleosides
US5808040A (en) * 1995-01-30 1998-09-15 Yale University L-nucleosides incorporated into polymeric structure for stabilization of oligonucleotides
US6296882B1 (en) * 2000-06-12 2001-10-02 Manuel Viamonte, Jr. Non-toxic mucosal disinfectant containing isopropyl alcohol, sesame oil, and lemon oil
US8076303B2 (en) 2005-12-13 2011-12-13 Spring Bank Pharmaceuticals, Inc. Nucleotide and oligonucleotide prodrugs
EP2427213B1 (en) * 2009-05-08 2015-04-01 Sciclone Pharmaceuticals, Inc. Alpha thymosin peptides as vaccine enhancers

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE147774C (no) *
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
US4594339A (en) * 1982-04-06 1986-06-10 Sloan-Kettering Institute For Cancer Research Anti-herpes virus compositions containing 5-substituted 1-2'(deoxy-2-'-substituted-β-d-arabinofuranosyl)pyrimedene nucleosides
US4666892A (en) * 1984-03-06 1987-05-19 Sloan-Kettering Memorial Cancer Center Method and composition for hepatitis treatment with pyrimidine nucleoside compounds

Also Published As

Publication number Publication date
PT101238A (pt) 1994-03-31
MD940152A (ro) 1995-12-31
NZ247188A (en) 1995-05-26
BR9306207A (pt) 1998-06-23
EE9400068A (et) 1995-12-15
YU23993A (sh) 1997-05-28
IL105169A0 (en) 1993-07-08
FR2689398B1 (fr) 1994-11-18
EP0565412A1 (en) 1993-10-13
SI9300144A (en) 1994-03-31
NO931246D0 (no) 1993-03-31
PH31116A (en) 1998-02-28
LV10191A (lv) 1994-10-20
US5432165A (en) 1995-07-11
LV10191B (en) 1995-04-20
FR2689398A1 (fr) 1993-10-08
CA2092356A1 (en) 1993-10-07
ES2105923B1 (es) 1998-07-01
JPH069403A (ja) 1994-01-18
AU662804B2 (en) 1995-09-14
GR930100111A (el) 1993-12-30
AP9300513A0 (en) 1993-04-30
WO1993019762A1 (en) 1993-10-14
CN1081879A (zh) 1994-02-16
ITTO930226A1 (it) 1994-10-05
AU3530293A (en) 1993-10-07
MX9301922A (es) 1993-10-01
OA10102A (en) 1996-12-18
ITTO930226A0 (it) 1993-04-05
AP372A (en) 1994-11-24
ES2105923A1 (es) 1997-10-16
IT1264332B1 (it) 1996-09-23
BE1009181A5 (fr) 1996-12-03

Similar Documents

Publication Publication Date Title
MD1224B2 (en) Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B
MY107843A (en) Anti-viral compounds.
KR880010777A (ko) 바이러스 억제제와 결합한 dsRNA로 인간의 바이러스 감염을 치료하는 방법
CA2293470A1 (en) Benzimidazole derivatives
NZ235244A (en) 2'-deoxy-2'-fluoro-ribonucleosides and compositions for the treatment of viral and parasitic diseases
WO2003063771A3 (en) N4-acylcytosine nucleosides for treatment of viral iinfections
DK0911033T3 (da) Anvendelse af konsensusinterferon til reduktion af bivirkningerne af interferonbehandling i viral hepatitis
BR9812232A (pt) Vìrus sincicial respiratório (rsv) humano subgrupo b, isolado, recombinantemente gerado , atenuado, vacina, processo para imunizar um indivìduo para induzir proteção contra o rsv subgrupo b, composição, processo para produzir rsv subgrupo b infeccioso atenuado, e, molécula isolada de ácido nucleico
CA2033044A1 (en) 6-substituted purine carbocyclic nucleosides
AU1854695A (en) The use of interferon subtypes in the preparation of medicaments to treat viral infections
CA2197319A1 (en) Lipid analogs for treating viral infections
EP0270317A3 (en) Pharmaceutical compositions for the treatment of diseases caused by viruses
ATE175873T1 (de) Weitere indolderivate mit antiviraler wirkung
ATE157370T1 (de) Oligonukleotide mit wirkung gegen das respiratorische synzytial virus
BR9913333A (pt) Inibição e tratamento do vìrus da hepatite b e flavivìrus com helioxatina e seus análogos
NO970847D0 (no) 2-£amino-6-(cyklopropylamino)-9H-purin-9-yl|-2-cyklopenten-1-metanol-succinat som anti-virusmiddel
ES2105923A1 (es) Composiciones para el tratamiento de una infeccion y una enfermedad causadas por el virus de la hepatitis b (hbv).
DK0531413T3 (da) Et antiviralt præparat indeholdende prostratin
ATE267198T1 (de) Synthese und anti-hiv und anti-hepatitis virus aktivität von 1,3-oxaselenolan nucleosiden
AP2001002181A0 (en) Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis C virus and other toga viruses.
PT87004A (pt) Process for the preparation of compositions for the treatment of viral infections and composites 3'-azide-2',3'-didesoxy-in osine and 3'-fluoro-2',3'-didesoxyguanosine
Eriksson et al. Is hypoxemia in cirrhotic patients due to a functional ‘hepato-pulmonal syndrome’?
RU93058325A (ru) Применение производных 1,3-оксатиолана для получения лекарственных препаратов для лечения или профилактики вирусной инфекции гепатита в, применение производных 1,3 - оксатиолана для лечения инфекций гепатита в, способ лечения гепатита в
KR960700741A (ko) 인터페론치료에 대한 무응답자의 c형 간염 치료방법(method of treating hepatitis c in non-pesponders to interferon treatment)
TW217986B (en) Compositions for the treatment of infection and disease caused by HBV